Today, IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2019 that found one-third of oncologists were unaware of evidence-based guidelines for these tests. To promote the survey to a global audience, IASLC has recorded podcast episodes on this topic in different languages. In this episode, host Dr. Misako Nagasaka leads a discussion in Japanese about biomarker testing with Dr.Terufumi Kato and Dr. Masahiro Tsuboi. To take the survey, visit: https://bit.ly/BiomarkerS24
Podkasten Lung Cancer Considered er innebygd på denne siden fra en åpen RSS feed. Alle filer, beskrivelser, illustrasjoner og andre metadata fra RSS-feeden tilhører podcasteieren og er ikke tilknyttet eller validert av Podplay.